GB0417740D0 - Methods and kit for the prognosis of breast cancer - Google Patents
Methods and kit for the prognosis of breast cancerInfo
- Publication number
- GB0417740D0 GB0417740D0 GB0417740A GB0417740A GB0417740D0 GB 0417740 D0 GB0417740 D0 GB 0417740D0 GB 0417740 A GB0417740 A GB 0417740A GB 0417740 A GB0417740 A GB 0417740A GB 0417740 D0 GB0417740 D0 GB 0417740D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- prognosis
- kit
- methods
- breast cancer
- breast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0417740A GB0417740D0 (en) | 2004-08-10 | 2004-08-10 | Methods and kit for the prognosis of breast cancer |
PT05763127T PT1781814E (en) | 2004-08-10 | 2005-07-27 | Methods and kit for the prognosis of breast cancer |
MX2007001640A MX2007001640A (en) | 2004-08-10 | 2005-07-27 | Methods and kit for the prognosis of breast cancer. |
AT05763127T ATE454474T1 (en) | 2004-08-10 | 2005-07-27 | METHOD AND KIT FOR PROGNOSIS OF BREAST CANCER |
CN201110315370.0A CN102443627B (en) | 2004-08-10 | 2005-07-27 | Kit for the prognosis of breast cancer |
PCT/GB2005/002971 WO2006016110A1 (en) | 2004-08-10 | 2005-07-27 | Methods and kit for the prognosis of breast cancer |
EP05763127A EP1781814B3 (en) | 2004-08-10 | 2005-07-27 | Methods and kit for the prognosis of breast cancer |
US11/573,487 US20100035240A1 (en) | 2004-08-10 | 2005-07-27 | Methods and kit for the prognosis of breast cancer |
CA002576113A CA2576113A1 (en) | 2004-08-10 | 2005-07-27 | Methods and kit for the prognosis of breast cancer |
DK05763127.7T DK1781814T3 (en) | 2004-08-10 | 2005-07-27 | Methods and kits for breast cancer prognosis |
CN2005800303728A CN101014720B (en) | 2004-08-10 | 2005-07-27 | Methods and kit for the prognosis of breast cancer |
AU2005271113A AU2005271113B2 (en) | 2004-08-10 | 2005-07-27 | Methods and kit for the prognosis of breast cancer |
ES05763127T ES2339132T7 (en) | 2004-08-10 | 2005-07-27 | METHODS AND KIT FOR THE FORECAST OF CANCER OF MAMA. |
DE602005018789T DE602005018789D1 (en) | 2004-08-10 | 2005-07-27 | METHOD AND KIT FOR THE PROGNOSIS OF BREAST CANCER |
JP2007525333A JP5117852B2 (en) | 2004-08-10 | 2005-07-27 | Prognosis method and kit for breast cancer |
GB0701676A GB2430741A (en) | 2004-08-10 | 2007-01-30 | Methods and Kit for the Prognosis of Breast Cancer |
HK07111076.7A HK1103422A1 (en) | 2004-08-10 | 2007-10-12 | Methods and kit for the prognosis of breast cancer |
JP2011198276A JP5634360B2 (en) | 2004-08-10 | 2011-09-12 | Prognosis method and kit for breast cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0417740A GB0417740D0 (en) | 2004-08-10 | 2004-08-10 | Methods and kit for the prognosis of breast cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0417740D0 true GB0417740D0 (en) | 2004-09-08 |
Family
ID=32982775
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0417740A Ceased GB0417740D0 (en) | 2004-08-10 | 2004-08-10 | Methods and kit for the prognosis of breast cancer |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101014720B (en) |
GB (1) | GB0417740D0 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2356462T (en) | 2008-11-11 | 2017-04-07 | Univ Michigan Regents | Anti-cxcr1 compositions and methods |
EP3360978A3 (en) | 2009-05-07 | 2018-09-26 | Veracyte, Inc. | Methods for diagnosis of thyroid conditions |
US8383358B2 (en) * | 2009-05-28 | 2013-02-26 | Abraxis Bioscience, Llc | Use of 2 anti-SPARC antibodies to predict response to melanoma chemotherapy |
CN102576016A (en) * | 2009-09-18 | 2012-07-11 | 阿布拉西斯生物科学有限责任公司 | Use of the SPARC microenvironment signature in the treatment of cancer |
US9193782B2 (en) | 2010-06-03 | 2015-11-24 | Abraxis Bioscience, Llc | Use of the SPARC microenvironment signature in the treatment of cancer |
CN102183655B (en) * | 2011-01-24 | 2014-06-11 | 中国人民解放军军事医学科学院生物医学分析中心 | New molecular marker CUEDC2 (CUE Domain Containing 2) protein for prognosis judgement in endocrine therapy of breast cancer |
CN105628919A (en) * | 2014-10-30 | 2016-06-01 | 上海市第十人民医院 | Application of CD166 as liver cancer diagnosis serum marker and kit thereof |
CN114606309A (en) | 2014-11-05 | 2022-06-10 | 威拉赛特公司 | Diagnostic system and method using machine learning and high-dimensional transcription data |
AU2016226253A1 (en) * | 2015-03-04 | 2017-09-21 | Veracyte, Inc. | Methods for assessing the risk of disease occurrence or recurrence using expression level and sequence variant information |
CN106337081B (en) * | 2016-02-02 | 2020-01-21 | 中国医学科学院肿瘤医院 | Correlation of SNP locus rs1054135 of FABP4 gene and triple negative breast cancer prognosis |
GB201608000D0 (en) * | 2016-05-06 | 2016-06-22 | Oxford Biodynamics Ltd | Chromosome detection |
US11217329B1 (en) | 2017-06-23 | 2022-01-04 | Veracyte, Inc. | Methods and systems for determining biological sample integrity |
CN107446023B (en) * | 2017-09-07 | 2020-03-27 | 华中科技大学同济医学院附属协和医院 | Polypeptide HIP-13 capable of antagonizing RNA binding activity of HuR protein and application thereof |
CN109182479A (en) * | 2018-07-27 | 2019-01-11 | 广州医科大学附属第医院 | A kind of real-time fluorescence quantitative PCR Universal fluorescence probe and its application |
-
2004
- 2004-08-10 GB GB0417740A patent/GB0417740D0/en not_active Ceased
-
2005
- 2005-07-27 CN CN2005800303728A patent/CN101014720B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN101014720A (en) | 2007-08-08 |
CN101014720B (en) | 2012-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1077583A1 (en) | Cudr as biomarker for cancer progression and therapeutic response | |
EP1824520A4 (en) | Methods of detecting prostate cancer | |
IL180997A0 (en) | Diagnostic methods and kits utilizing platelet biomarkers for cancer | |
ZA200610132B (en) | Therapy of platinum-resistant cancer | |
IL179059A0 (en) | Method of diagnosing prostate cancer | |
EP1937845A4 (en) | Micro-rna-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer | |
GB0519405D0 (en) | Cancer therapy prognosis and target | |
IL180601A0 (en) | Methods and compositions for the detection of ovarian cancer | |
SI2100618T1 (en) | An anti-PDGFRalpha antibody for use in the treatment of metastatic bone cancer | |
EP1697497A4 (en) | Liver cancer biomarkers | |
EP2061899A4 (en) | Biomarkers for prostate cancer and methods using the same | |
EP1747284A4 (en) | Diagnosis and therapeutics for cancer | |
EP2000543A4 (en) | Method for the molecular diagnosis of prostate cancer and kit for implementing same | |
EP1735620A4 (en) | Lung cancer biomarkers | |
EP1664716A4 (en) | Biomarkers in cancer | |
EP1838330A4 (en) | Treatment of solid cancers | |
EP1802764A4 (en) | Biomarkers for breast cancer | |
IL182813A0 (en) | Methods and systems for prognosis and treatment of solid tumors | |
GB0512299D0 (en) | Diagnosis prognosis and prediction of recurrence of breast cancer | |
EP1742654A4 (en) | Anti-lfl2 antibodies for the diagnosis, prognosis and treatment of cancer | |
IL179715A0 (en) | Diagnosing or predicting the course of breast cancer | |
IL179129A0 (en) | Kit for treatment of cancer | |
EP1709421A4 (en) | Methods for diagnosis and pronosis of cancers of epithelial origin | |
PT1611890E (en) | Methods for assessing and treating cancer | |
GB0417740D0 (en) | Methods and kit for the prognosis of breast cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |